Niquitin Mini (Nicotine)

Nicotine, the active ingredient in Niquitin Mini, is a nicotine replacement therapy presented as an oromucosal formulation for oromucosal use. It is intended to aid adult smokers in reducing cravings and withdrawal symptoms associated with tobacco cessation, providing a controlled dose of nicotine to support the quitting process.

GNH USA supplies Niquitin Mini as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory compliance across markets.

Niquitin Mini is used as a nicotine replacement therapy to assist individuals who are trying to quit tobacco.

- Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms during the quitting process. - Tobacco dependence: provides a controlled nicotine dose to lessen the urge to smoke. - Relapse prevention: supports individuals who have recently quit by managing occasional nicotine cravings.

Niquitin Mini may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation or soreness. - Nausea or upset stomach. - Throat discomfort. - Headache. - Dizziness. - Increased salivation.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with rash, swelling, or difficulty breathing. - Persistent high blood pressure. - Cardiac arrhythmia. - Severe nausea or vomiting leading to dehydration. - Unexplained weight loss. - Mood changes such as depression or anxiety.

Before using Niquitin Mini, consider the following safety measures.

- Assess medical history: disclose cardiovascular disease, hypertension, or diabetes. - Avoid use in children: not intended for individuals under the legal smoking age. - Monitor for allergic reactions: discontinue if rash, swelling, or breathing difficulty occurs. - Caution with other nicotine sources: avoid simultaneous use of cigarettes, e‑cigarettes, or other NRT products. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Niquitin Mini can interact with certain medications and substances.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase nicotine effects and cardiovascular risk. - Certain antihypertensives: nicotine can counteract blood‑pressure‑lowering effects.

Moderate Interactions (Monitor Closely): - Caffeine‑containing products: may enhance stimulant effects, leading to jitteriness. - Psychiatric medications (e.g., antipsychotics): nicotine may alter drug metabolism. - Alcohol: combined use can increase nausea and dizziness. - Herbal supplements affecting liver enzymes (e.g., St. John’s wort): may modify nicotine clearance.